Pulmongene announces to present PMG1015 Phase 1b Clinical Trial Results as a Late-Breaking Abstract at European Respiratory Society Congress (ERS) 2025
Beijing, China – September 2, 2025 – Pulmongene Ltd., a […]
Pulmongene Announces First Patient Dosed in Phase 1b Clinical Trial Evaluating PMG1015 in Idiopathic Pulmonary Fibrosis Patients
On July 5, 2023, Pulmongene Ltd. announced that its inv